CNS Involvement in AML Patient Treated with 5-Azacytidine

about

Acute Myeloid Leukemia Relapse Presenting as Complete Monocular Vision Loss due to Optic Nerve Involvement.

P2860

Q41138574-FE64A2DF-7751-4730-A9E6-AA185872A857

P2860

CNS Involvement in AML Patient Treated with 5-Azacytidine

Item

http://www.wikidata.org/entity/Q42853619

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

CNS Involvement in AML Patient Treated with 5-Azacytidine

@en

CNS Involvement in AML Patient Treated with 5-Azacytidine

@nl

type

Item

label

CNS Involvement in AML Patient Treated with 5-Azacytidine

@en

CNS Involvement in AML Patient Treated with 5-Azacytidine

@nl

prefLabel

CNS Involvement in AML Patient Treated with 5-Azacytidine

@en

CNS Involvement in AML Patient Treated with 5-Azacytidine

@nl

P1476

CNS Involvement in AML Patient Treated with 5-Azacytidine

@en

P2093

Athina Prasouli

http://www.w3.org/2001/XMLSchema#string

Christina Economopoulou

http://www.w3.org/2001/XMLSchema#string

Christoforos Roumpakis

http://www.w3.org/2001/XMLSchema#string

Diamantina Vasilatou

http://www.w3.org/2001/XMLSchema#string

Efthymia Bazani

http://www.w3.org/2001/XMLSchema#string

George Dimitriadis

http://www.w3.org/2001/XMLSchema#string

Petros Karakitsos

http://www.w3.org/2001/XMLSchema#string

Sotirios Papageorgiou

http://www.w3.org/2001/XMLSchema#string

Vasiliki Pappa

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia.

Central nervous system involvement in adult acute lymphocytic leukemia.

Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation.

Current management and challenges of malignant disease in the CNS in paediatric leukaemia.

Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia).

Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older.

The importance of CD7 and CD56 antigens in acute leukaemias.

Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease.

P304

937203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/937203

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265418138

http://www.w3.org/2001/XMLSchema#string

P698

25197583

http://www.w3.org/2001/XMLSchema#string

P932

4150438

http://www.w3.org/2001/XMLSchema#string

CNS Involvement in AML Patient Treated with 5-Azacytidine

about

P2860

P2860

CNS Involvement in AML Patient Treated with 5-Azacytidine

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932